Back
Phathom Pharmaceuticals Vs. ResMed Industry Stock Comparison
Buy
67
PHAT
Phathom Pharmaceuticals
Last Price:
9.66
Seasonality Move:
6.71%
Sell
38
RMD
ResMed
Last Price:
205.76
Seasonality Move:
9.91%
Buy
67
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $10.19. The Score for PHAT is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
38
ResMed (RMD)
is a Sell
Is ResMed a Buy, Sell or Hold?
- The current ResMed [RMD] share price is $209.34. The Score for RMD is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
- RMD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $10.19
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PHAT is experiencing selling pressure, which indicates risk of future bearish movement.
RMD Stock Price Chart
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 50.53 | Buy |
| Chaikin Money Flow: | -205133 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.51 - 10.61) | Buy |
| Bollinger Bands (100): | (7.71 - 10.63) | Buy |
RMD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.51 | Buy |
| Relative Strength Index (14 RSI): | 49.79 | Sell |
| Chaikin Money Flow: | 413656 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (206.91 - 221.49) | Sell |
| Bollinger Bands (100): | (177.2 - 206.68) | Buy |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.42 | Sell |
| 20-day SMA: | 10.28 | Sell |
| 50-day SMA: | 10.13 | Buy |
| 200-day SMA: | 9.64 | Buy |
| 8-day EMA: | 10.3 | Sell |
| 20-day EMA: | 10.22 | Sell |
| 50-day EMA: | 9.93 | Buy |
| 200-day EMA: | 9.81 | Buy |
RMD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 212.83 | Sell |
| 20-day SMA: | 215.36 | Sell |
| 50-day SMA: | 200.96 | Buy |
| 200-day SMA: | 173.15 | Buy |
| 8-day EMA: | 211.48 | Sell |
| 20-day EMA: | 211.32 | Sell |
| 50-day EMA: | 203.36 | Buy |
| 200-day EMA: | 189.19 | Buy |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.26 per share, an increase next quarter of $0.34 per share, a decrease this year of $1.15 per share, and an increase next year of $1.18 per share.
ResMed Earnings Growth & RMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, an increase next quarter of $0.07 per share, an increase this year of $1.20 per share, and an increase next year of $0.90 per share.
Phathom Pharmaceuticals Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ResMed Technical Analysis
| May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | May 28 | May 29 | May 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 16 | 17 | 20 | 21 | 22 | 23 | 24 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||